Cross-source evidence timeline

Insulin glargine-aldy research timeline

Follow 6 selected, directly cited source records from April 29, 2026 through October 19, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

6Selected records
1Source years
1Evidence lanes
October 19, 2026Latest source date

Source year

2026

6 records
  1. Regulatory

    Insulin glargine-aldy DailyMed SPL version 7↗

    DailyMed lists Structured Product Labeling version 7 for the reviewed Insulin glargine-aldy label family with a published date of 2026-10-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

  2. Regulatory

    Insulin glargine-aldy DailyMed SPL version 6↗

    DailyMed lists Structured Product Labeling version 6 for the reviewed Insulin glargine-aldy label family with a published date of 2026-09-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

  3. Regulatory

    Insulin glargine-aldy DailyMed SPL version 5↗

    DailyMed lists Structured Product Labeling version 5 for the reviewed Insulin glargine-aldy label family with a published date of 2026-07-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

  4. Regulatory

    Insulin glargine-aldy DailyMed SPL version 2↗

    DailyMed lists Structured Product Labeling version 2 for the reviewed Insulin glargine-aldy label family with a published date of 2026-06-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

  5. Regulatory

    Insulin glargine-aldy DailyMed SPL version 1↗

    DailyMed lists Structured Product Labeling version 1 for the reviewed Insulin glargine-aldy label family with a published date of 2026-06-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

  6. Regulatory

    Drugs@FDA application BLA761412↗

    The official Drugs@FDA dataset lists original submission 1 for BLA 761412 with status AP dated 2026-04-29, and names insulin glargine-aldy among the application record's active ingredients.↗